Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-center Phase II, Non-randomized Study of MRgFUS Versus EBRT in Patients With Metastatic Non-spinal Bone Disease: Palliative Strategy for Cancer-Induced Bone Pain

NCT03404362 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT03404362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03404362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-center Phase II, Non-randomized Study of MRgFUS Versus EBRT in Patients With Metastatic Non-spinal Bone Disease: Palliative Strategy for Cancer-Induced Bone Pain
Lead sponsor
University of Roma La Sapienza
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2017
Completion date
September 30, 2020
Enrollment
198 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, secondary bone cancer